Cross, Darren A.E.
AstraZeneca,
United Kingdom
2025 Rank: 162961
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 6023 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 162961 | 185388 |
| Total Cites | 12478 | 13069 |
| H-index | 33 | 34 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 7100 | 7332 |
| Number of Single+First+Last Authored Papers | 14 | 14 |
| Total Cites to Single+First+Last Authored Papers | 8402 | 8710 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10739 | 11107 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.18 |
| Self-Citation Percentage |
4.52%
|
|
Cross, Darren A.E.
AstraZeneca,
United Kingdom
2024 Rank: 162319
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 6069 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 162319 | 182201 |
| Total Cites | 11538 | 12102 |
| H-index | 30 | 32 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 6819 | 7049 |
| Number of Single+First+Last Authored Papers | 14 | 14 |
| Total Cites to Single+First+Last Authored Papers | 8001 | 8296 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9912 | 10266 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.18 |
| Self-Citation Percentage |
4.66%
|
|
Cross, Darren A.E.
AstraZeneca,
United Kingdom
2023 Rank: 155218
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 5875 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 155218 | 176741 |
| Total Cites | 10629 | 11171 |
| H-index | 30 | 31 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 6538 | 6767 |
| Number of Single+First+Last Authored Papers | 14 | 14 |
| Total Cites to Single+First+Last Authored Papers | 7575 | 7863 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9102 | 9444 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.18 |
| Self-Citation Percentage |
4.85%
|
|
Cross, Darren A.E.
AstraZeneca,
United Kingdom
2022 Rank: 152596
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 5775 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 152596 | 173693 |
| Total Cites | 9626 | 10148 |
| H-index | 27 | 28 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 6198 | 6422 |
| Number of Single+First+Last Authored Papers | 14 | 14 |
| Total Cites to Single+First+Last Authored Papers | 7057 | 7333 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8258 | 8588 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.18 |
| Self-Citation Percentage |
5.14%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.